S&P Global Launches $2B Private Note Offering for Mobility Division
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 48 minutes ago
0mins
Should l Buy SPGI?
Source: seekingalpha
- Private Note Offering: S&P Global's Mobility Global division has initiated a $2 billion private offering of senior notes aimed at raising funds for its upcoming spin-off, facilitating asset transfers and cash payments.
- Credit Facility: The division has also entered into a $500 million senior unsecured revolving credit facility, enhancing its financial flexibility to meet funding needs during the separation process.
- Use of Proceeds: Proceeds from the note offering will be used to finance a cash payment to S&P Global in exchange for certain assets and liabilities upon completion of the spin-off, with remaining funds allocated for fees and general corporate purposes.
- Spin-off Timeline: S&P Global plans to complete the separation of Mobility Global by mid-2026, which is expected to enhance its competitiveness in the automotive data analytics market while creating value for shareholders.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SPGI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SPGI
Wall Street analysts forecast SPGI stock price to rise
15 Analyst Rating
14 Buy
1 Hold
0 Sell
Strong Buy
Current: 403.150
Low
546.00
Averages
617.77
High
675.00
Current: 403.150
Low
546.00
Averages
617.77
High
675.00
About SPGI
S&P Global Inc. provides essential intelligence. Its operations consist of five businesses: S&P Global Market Intelligence (Market Intelligence), S&P Global Ratings (Ratings), S&P Global Commodity Insights (Commodity Insights), S&P Global Mobility (Mobility) and S&P Dow Jones Indices (Indices). Market Intelligence is a global provider of multi-asset-class data and analytics integrated with purpose-built workflow solutions. Ratings is an independent provider of credit ratings, research, and analytics, offering investors and other market participants information, ratings and benchmarks. Commodity Insights is an independent provider of information and benchmark prices for the commodity and energy markets. Mobility is a provider of solutions serving the full automotive value chain, including vehicle manufacturers and retailers. Indices is a global index provider that maintains a variety of valuation and index benchmarks for investment advisors, wealth managers and institutional investors.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
S&P Global Launches $2B Private Note Offering for Mobility Division
- Private Note Offering: S&P Global's Mobility Global division has initiated a $2 billion private offering of senior notes aimed at raising funds for its upcoming spin-off, facilitating asset transfers and cash payments.
- Credit Facility: The division has also entered into a $500 million senior unsecured revolving credit facility, enhancing its financial flexibility to meet funding needs during the separation process.
- Use of Proceeds: Proceeds from the note offering will be used to finance a cash payment to S&P Global in exchange for certain assets and liabilities upon completion of the spin-off, with remaining funds allocated for fees and general corporate purposes.
- Spin-off Timeline: S&P Global plans to complete the separation of Mobility Global by mid-2026, which is expected to enhance its competitiveness in the automotive data analytics market while creating value for shareholders.
See More
S&P Global CEO to Participate in Strategic Conference
- Conference Participation: Martina Cheung, CEO of S&P Global, will participate in Bernstein's 42nd Annual Strategic Decisions Conference on May 27, 2026, in New York, showcasing the company's leadership in strategic decision-making.
- Webcast Details: The session will be webcast live on the company's Investor Relations website, with a replay available within two hours post-event, accessible for 90 days until August 24, 2026, ensuring timely access to critical information for investors.
- Investor Meetings: Mark Grant, Senior Vice President of Investor Relations, will join for investor meetings, enhancing communication with stakeholders and demonstrating the company's commitment to transparency and accountability in the capital markets.
- Company Overview: S&P Global empowers businesses, governments, and individuals with trusted data and insights to make informed decisions, emphasizing its role in fostering confidence and growth in a rapidly changing global landscape.
See More
S&P Global to Present at Bernstein's Strategic Decisions Conference
- Conference Participation: Martina Cheung, CEO of S&P Global, will participate in Bernstein's 42nd Annual Strategic Decisions Conference on May 27, 2026, in New York, scheduled to speak from 11:00 a.m. to 11:50 a.m. EDT, aiming to enhance investor engagement.
- Webcast Arrangements: The session will be webcast live through the company's Investor Relations website, with a replay available within two hours post-presentation and accessible for 90 days until August 24, 2026, ensuring that investors who cannot attend live can still access the information.
- Investor Meeting Involvement: Mark Grant, Senior Vice President of Investor Relations, will also join the conference, further strengthening communication with investors and demonstrating the company's commitment to transparency and investor relations.
- Company Background Overview: S&P Global focuses on enabling businesses and individuals to make informed decisions in a rapidly changing global landscape through world-leading benchmarks, data, and insights, highlighting its critical role in investment assessments across capital and commodities markets.
See More
S&P Global: A Hidden Investment Opportunity
- Diverse Revenue Streams: S&P Global generates only 12% of its revenue from market indexes, while market data services account for nearly one-third, showcasing its strong competitive position in the financial information sector that can withstand market fluctuations.
- Consistent Performance Growth: The company reported an 8% year-over-year revenue increase and a 14% rise in earnings per share last year, marking its 12th consecutive year of revenue growth, indicating the stability and profitability of its business model.
- High Market Barriers: S&P Global holds significant positions in niche markets like energy trading and automotive research, making it difficult for competitors to replicate its reputation and expertise, thereby ensuring its leadership in the industry.
- Investor Confidence: Despite a 20% decline in stock price since February, analysts overwhelmingly rate the stock as a strong buy, with a price target of $533.95, reflecting a 25% upside from current levels and indicating strong market confidence in its long-term performance.
See More
Teva Pharmaceutical Stock Doubles, Analysts Remain Optimistic
- Stock Price Surge: Teva Pharmaceutical's stock has soared over 100% in the past 12 months, reflecting strong market confidence in its recovery, with analysts generally optimistic about its future performance.
- Analyst Ratings Positive: In a survey by S&P Global, 12 out of 13 analysts rated Teva as a 'buy' or 'strong buy', indicating recognition of its potential 11% upside in the market.
- Significant Sales Growth: Teva's Austedo drug saw first-quarter sales jump 41% year-over-year to $578 million, driving overall performance improvements and further boosting market confidence.
- Improved Financial Health: As of March 31, 2026, Teva's financial leverage dropped to 67%, and the company expects to realize approximately $470 million in net savings from transformation initiatives, demonstrating proactive efforts in cost-cutting and financial health improvement.
See More
Goldman Sachs Bullish on UnitedHealth Group's Prospects
- Goldman Sachs Confidence: Goldman Sachs added UnitedHealth Group to its U.S. conviction list, believing that its performance in the Medicare Advantage market is approaching an inflection point, which is expected to drive profit improvement and reflects strong bullish sentiment towards the stock.
- Medicare Advantage Strength: As of March 2026, UnitedHealth serves over 7.5 million Medicare Advantage members, and despite stock volatility over the past 18 months, Goldman Sachs believes the company is nearing the bottom of its underwriting cycle, with potential for future profit growth.
- Positive Market Response: Goldman Sachs' 12-month price target indicates an upside potential of about 12%, and among 28 analysts, 22 rated the stock as a
See More
S&P Global Launches $2B Private Note Offering for Mobility Division
- Private Note Offering: S&P Global's Mobility Global division has initiated a $2 billion private offering of senior notes aimed at raising funds for its upcoming spin-off, facilitating asset transfers and cash payments.
- Credit Facility: The division has also entered into a $500 million senior unsecured revolving credit facility, enhancing its financial flexibility to meet funding needs during the separation process.
- Use of Proceeds: Proceeds from the note offering will be used to finance a cash payment to S&P Global in exchange for certain assets and liabilities upon completion of the spin-off, with remaining funds allocated for fees and general corporate purposes.
- Spin-off Timeline: S&P Global plans to complete the separation of Mobility Global by mid-2026, which is expected to enhance its competitiveness in the automotive data analytics market while creating value for shareholders.
See More
S&P Global CEO to Participate in Strategic Conference
- Conference Participation: Martina Cheung, CEO of S&P Global, will participate in Bernstein's 42nd Annual Strategic Decisions Conference on May 27, 2026, in New York, showcasing the company's leadership in strategic decision-making.
- Webcast Details: The session will be webcast live on the company's Investor Relations website, with a replay available within two hours post-event, accessible for 90 days until August 24, 2026, ensuring timely access to critical information for investors.
- Investor Meetings: Mark Grant, Senior Vice President of Investor Relations, will join for investor meetings, enhancing communication with stakeholders and demonstrating the company's commitment to transparency and accountability in the capital markets.
- Company Overview: S&P Global empowers businesses, governments, and individuals with trusted data and insights to make informed decisions, emphasizing its role in fostering confidence and growth in a rapidly changing global landscape.
See More
S&P Global to Present at Bernstein's Strategic Decisions Conference
- Conference Participation: Martina Cheung, CEO of S&P Global, will participate in Bernstein's 42nd Annual Strategic Decisions Conference on May 27, 2026, in New York, scheduled to speak from 11:00 a.m. to 11:50 a.m. EDT, aiming to enhance investor engagement.
- Webcast Arrangements: The session will be webcast live through the company's Investor Relations website, with a replay available within two hours post-presentation and accessible for 90 days until August 24, 2026, ensuring that investors who cannot attend live can still access the information.
- Investor Meeting Involvement: Mark Grant, Senior Vice President of Investor Relations, will also join the conference, further strengthening communication with investors and demonstrating the company's commitment to transparency and investor relations.
- Company Background Overview: S&P Global focuses on enabling businesses and individuals to make informed decisions in a rapidly changing global landscape through world-leading benchmarks, data, and insights, highlighting its critical role in investment assessments across capital and commodities markets.
See More
S&P Global: A Hidden Investment Opportunity
- Diverse Revenue Streams: S&P Global generates only 12% of its revenue from market indexes, while market data services account for nearly one-third, showcasing its strong competitive position in the financial information sector that can withstand market fluctuations.
- Consistent Performance Growth: The company reported an 8% year-over-year revenue increase and a 14% rise in earnings per share last year, marking its 12th consecutive year of revenue growth, indicating the stability and profitability of its business model.
- High Market Barriers: S&P Global holds significant positions in niche markets like energy trading and automotive research, making it difficult for competitors to replicate its reputation and expertise, thereby ensuring its leadership in the industry.
- Investor Confidence: Despite a 20% decline in stock price since February, analysts overwhelmingly rate the stock as a strong buy, with a price target of $533.95, reflecting a 25% upside from current levels and indicating strong market confidence in its long-term performance.
See More
Teva Pharmaceutical Stock Doubles, Analysts Remain Optimistic
- Stock Price Surge: Teva Pharmaceutical's stock has soared over 100% in the past 12 months, reflecting strong market confidence in its recovery, with analysts generally optimistic about its future performance.
- Analyst Ratings Positive: In a survey by S&P Global, 12 out of 13 analysts rated Teva as a 'buy' or 'strong buy', indicating recognition of its potential 11% upside in the market.
- Significant Sales Growth: Teva's Austedo drug saw first-quarter sales jump 41% year-over-year to $578 million, driving overall performance improvements and further boosting market confidence.
- Improved Financial Health: As of March 31, 2026, Teva's financial leverage dropped to 67%, and the company expects to realize approximately $470 million in net savings from transformation initiatives, demonstrating proactive efforts in cost-cutting and financial health improvement.
See More
Goldman Sachs Bullish on UnitedHealth Group's Prospects
- Goldman Sachs Confidence: Goldman Sachs added UnitedHealth Group to its U.S. conviction list, believing that its performance in the Medicare Advantage market is approaching an inflection point, which is expected to drive profit improvement and reflects strong bullish sentiment towards the stock.
- Medicare Advantage Strength: As of March 2026, UnitedHealth serves over 7.5 million Medicare Advantage members, and despite stock volatility over the past 18 months, Goldman Sachs believes the company is nearing the bottom of its underwriting cycle, with potential for future profit growth.
- Positive Market Response: Goldman Sachs' 12-month price target indicates an upside potential of about 12%, and among 28 analysts, 22 rated the stock as a
See More
